Literature DB >> 8855303

A mechanism for the inhibition of fever by a virus.

A Alcamí1, G L Smith.   

Abstract

Poxviruses encode proteins that block the activity of cytokines. Here we show that the study of such virulence factors can contribute to our understanding of not only virus pathogenesis but also the physiological role of cytokines. Fever is a nonspecific response to infection that contributes to host defense. Several cytokines induce an elevation of body temperature when injected into animals, but in naturally occurring fever it has been difficult to show that any cytokine has a critical role. We describe the first example of the suppression of fever by a virus and the molecular mechanism leading to it. Several vaccinia virus strains including smallpox vaccines express soluble interleukin 1 (IL-1) receptors, which bind IL-1 beta but not IL-1 alpha. These viruses prevent the febrile response in infected mice, whereas strains that naturally or through genetic engineering lack the receptor induce fever. Repair of the defective IL-1 beta inhibitor in the smallpox vaccine Copenhagen, a more virulent virus than the widely used vaccine strains Wyeth and Lister, suppresses fever and attenuates the disease. The vaccinia-induced fever was inhibited with antibodies to IL-1 beta. These findings provide strong evidence that IL-1 beta, and not other cytokines, is the major endogenous pyrogen in a poxvirus infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855303      PMCID: PMC38278          DOI: 10.1073/pnas.93.20.11029

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Cytokine receptors encoded by poxviruses: a lesson in cytokine biology.

Authors:  A Alcamí; G L Smith
Journal:  Immunol Today       Date:  1995-10

2.  Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice.

Authors:  H Zheng; D Fletcher; W Kozak; M Jiang; K J Hofmann; C A Conn; D Soszynski; C Grabiec; M E Trumbauer; A Shaw
Journal:  Immunity       Date:  1995-07       Impact factor: 31.745

3.  Cytokine measurements in septic shock.

Authors:  C A Dinarello; J G Cannon
Journal:  Ann Intern Med       Date:  1993-10-15       Impact factor: 25.391

4.  Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae.

Authors:  S J Hughes; L H Johnston; A de Carlos; G L Smith
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

5.  Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice.

Authors:  W Kozak; H Zheng; C A Conn; D Soszynski; L H van der Ploeg; M J Kluger
Journal:  Am J Physiol       Date:  1995-11

6.  Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection.

Authors:  I A Ramshaw; M E Andrew; S M Phillips; D B Boyle; B E Coupar
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

7.  Behavioral thermoregulation in mice inoculated with influenza virus.

Authors:  M S Klein; C A Conn; M J Kluger
Journal:  Physiol Behav       Date:  1992-12

8.  Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins.

Authors:  K Mossman; C Upton; R M Buller; G McFadden
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

9.  Low dosages of interleukin 1 protect mice against lethal cerebral malaria.

Authors:  J H Curfs; J W van der Meer; R W Sauerwein; W M Eling
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

10.  Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice.

Authors:  Z Chai; S Gatti; C Toniatti; V Poli; T Bartfai
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  39 in total

1.  A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.

Authors:  A Bowie; E Kiss-Toth; J A Symons; G L Smith; S K Dower; L A O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.

Authors:  Michael L Davies; Janet J Sei; Nicholas A Siciliano; Ren-Huan Xu; Felicia Roscoe; Luis J Sigal; Laurence C Eisenlohr; Christopher C Norbury
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

3.  The inflammasome as a target of modulation by DNA viruses.

Authors:  Lisi Amsler; Daniel Malouli; Victor DeFilippis
Journal:  Future Virol       Date:  2013-04-01       Impact factor: 1.831

4.  Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity.

Authors:  Ariana G Bravo Cruz; Aiguo Han; Edward J Roy; Arielle B Guzmán; Rita J Miller; Elizabeth A Driskell; William D O'Brien; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  A comparison of the effect of molluscum contagiosum virus MC159 and MC160 proteins on vaccinia virus virulence in intranasal and intradermal infection routes.

Authors:  Sunetra Biswas; Geoffrey L Smith; Edward J Roy; Brian Ward; Joanna L Shisler
Journal:  J Gen Virol       Date:  2018-02       Impact factor: 3.891

Review 6.  Subversion of cytokine networks by virally encoded decoy receptors.

Authors:  Megan L Epperson; Chung A Lee; Daved H Fremont
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

7.  Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation.

Authors:  Motti Gerlic; Benjamin Faustin; Antonio Postigo; Eric Chi-Wang Yu; Martina Proell; Naran Gombosuren; Maryla Krajewska; Rachel Flynn; Michael Croft; Michael Way; Arnold Satterthwait; Robert C Liddington; Shahram Salek-Ardakani; Shu-ichi Matsuzawa; John C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-19       Impact factor: 11.205

8.  TLR3 increases disease morbidity and mortality from vaccinia infection.

Authors:  Martha Hutchens; Kathryn E Luker; Peter Sottile; Joanne Sonstein; Nicholas W Lukacs; Gabriel Núñez; Jeffrey L Curtis; Gary D Luker
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

9.  Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.

Authors:  Aodhnait S Fahy; Richard H Clark; Emily F Glyde; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

10.  Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence.

Authors:  Caroline Gubser; Rory Goodbody; Andrea Ecker; Gareth Brady; Luke A J O'Neill; Nathalie Jacobs; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.